Phenyl quinolines and their use as estrogenic agents

Details Phenyl quinolines and their use as estrogenic agents Phenyl quinolines and their use as estrogenic agents

2006-05-31

2009-12-15

Seaman, D. Margaret (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

Reexamination Certificate

active

07632845

ABSTRACT:
This invention provides estrogen receptor modulators of formula I, having the structurewherein,R1, R2, R3, R4, R5, and R6are as defined in the specification, or a N-oxide thereof or a pharmaceutically acceptable salt thereof or a prodrug thereof.

REFERENCES:
patent: 4418068 (1983-11-01), Jones
patent: 5126351 (1992-06-01), Luzzio et al.
patent: 5998402 (1999-12-01), Miller et al.
patent: 7084276 (2006-08-01), Vu et al.
patent: 0 835 867 (1998-04-01), None
patent: 01/24785 (2001-04-01), None
patent: 02/04418 (2002-01-01), None
patent: 02/094268 AL (2002-11-01), None
patent: 02/094788 AL (2002-11-01), None
patent: 03/051805 (2003-06-01), None
patent: 03/051860 (2003-06-01), None
Lacreuse, Physiology & behavior, vol. 96, pp. 448-456, 1009.
Radjabian CA 143:373009, abstract only of Faslnamah-i Giyahan-i Daruyi, vol. 4(Suppl. 1), pp. 33-41, 2005.
Al-Azzawi, F., “The menopause and its treatment in perspective,” Postgraduate Medical Journal 77: 292-304 (2001).
Bhat, R. A. et al., “A Novel Human Estrogen Receptor β: Identification and Functional Analysis of Additional N-terminal Amino Acids,” Journal of Steroid Biochemistry & Molecular Biology 67: 233-240 (1998).
Black, L. J. et al., “Uterine Bioassay of Tamoxifen, Trioxifene and a New Estrogen Antagonist (LY117018) in Rats and Mice,” Life Sciences, 26, 1453 (1980).
Brincat, M. P., “Hormone replacement therapy and the skin,” Maturitas 35: 107-117 (2000).
Calvin, M., “Oestrogens and Wound Healing,” Maturitas 34: 195-210 (2000).
Chemical Abstract Service; Lakhani, R. R. et al., Database Accession No. 1992:448192; RN 141853-28-3; 141853-36-3; 141853-44-3; 141853-52-3 abstract &Acta Ciencia Indica, Chemistry, 1991, 17C(1): 47-54.
Chemical Abstracts Service; Gyul 'budagyan, L. V. et al., Database Accession No. 1969:28794; RN 21202-81-3; 21202-99-3; 21203-00-9; 21203-01-0; 21203-02-1; 21203-03-2 abstract &Armyanskii Khimicheskii Zhurnal, 1968, 21(5): 418-21.
Chemical Abstracts Service; Hamana, M. et al., Database Accession No. 1977:567845; RN 64388-10-9 abstract &Chemical & Pharmaceutical Bulletin, 1977, 25(6): 1256-64.
Chemical Abstracts Service; Lakhani, R. R. et al., Database Accession No. 1998:549419; RN 116720-97-9; 116721-05-2; 116721-13-2; 116721-21-2 abstract &Journal of the Indian Chemical Society, 1988, 65(3): 197-9.
Chemical Abstracts Service; Lakhani, R. R. et al., Database Accession No. 1988:549314; RN 116734-27-1; 116734-35-1 abstract &Journal of the Institution of Chemists(India), 1987, 59(5): 230-2.
Couse, J. F. et al., “Tissue Distribution and Quantitative Analysis of Estrogen Receptor-α(ERα) and Estrogen Receptor-β (ERβ) Messenger Ribonucleic Acid in the Wild-Type and ERα-Knockout Mouse,” Endocrinology 138: 4613-4621 (1997).
Cowley, S. M. et al., “Estrogen Receptors α and β Form Heterodimers on DNA,” Journal of Biological Chemistry 272: 19858-19862 (1997).
Crandall, C. J. “Estrogen Replacement Therapy and Colon Cancer: A Clinical Review,” Journal of Womens Health & Gender Based Medicine 8: 1155-1166 (1999).
Epperson, C. N. et al., “Gonadal Steroids in the Treatment of Mood Disorders,” Psychosomatic Medicine 61: 676-697 (1999).
Finking, G. et al., “Die Wirkungen von Östrogen im kardiovaskulären System,” Zeitschrift fur Kardiologie 89: 442-453 (2000) (English abstract included).
Fitzpatrick, S. L. et al., “Expression of Estrogen Receptor-β Protein in Rodent Ovary,” Endocrinology 140: 2581-2591(1999).
Goldstein, S. R. et al., “A Pharmacological review of selective oestrogen receptor modulators,” Human Reproduction Update 6: 212-224 (2000).
Green, S. et al., “Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A,” Nature 320: 134-9 (1986).
Hall, J. M. et al., “The Multifaceted Mechanisms of Estradiol and Estrogen Receptor Signaling,” Journal of Biological Chemistry 276: 36869-36872 (2001).
Hurn, P. D. et al., “Estrogen as a Neuroprotectant in Stroke,” Journal of Cerebral Blood Flow & Metabolism 20: 631-652 (2000).
Kuiper, G. et al., “Cloning of a novel estrogen receptor expressed in rat prostate and ovary,” Proceedings of the National Academy of Sciences of the United States of America 93: 5925-5930 (1996).
Kuiper, G. et al., “Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β,” Endocrinology 138: 863-870.
Levin, E. R. “Cellular Functions of the Plasma Membrane Estorgen Receptor,” Trends in Endocrinology & Metabolism 10: 374-377 (1999).
Levin, E. R., “Genome and Hormones: Gender Differences in PhysiologyInvited Review: Cell localization, physiology, and nongenomic actions of estrogen receptors,” Journal of Applied Physiology 91: 1860-1867 (2001).
McDonnell, D. P., “Selective Estrogen Receptor Modulators (SERMs): A First Step in the Development of Perfect Hormone Replacement Therapy Regimen,” Journal of the Society for Gynecologic Investigation 7: S10-S15 (2000).
McDonnell, D. P., Principles Of Molecular Regulation, Ch. 20, Humana Press,. pp. 351-361(2000) Totowa, New Jersey.
McKenna, N. J. et al., “Nuclear Receptor Coregulators: Cellular and Molecular Biology,” Endocrine Reviews 20: 321-344 (1999).
Mendelsohn, M. E. et al., “The Protective Effects of Estrogen on the Cardiovascular System,” New England Journal of Medicine 340: 1801-1811 (1999).
Meyers, Marvin J, et al., “Estrogen Receptor Subtype-Selective Ligands: Asymmetric Synthesis and Biological Evaluation of cis- and trans-5,11-Dialkyl-5,6,11,12-tetrahydrochrysenes,”J. Med. Chem. (1999), 42(13), 2456-2468.
Moggs, J. G. et al., “Estrogen receptors: orchestrators of pleiotropic cellular responses,” EMBO Reports 2: 775-781 (2001).
Monk, D. et al., “Use of Estrogens for the Prevention and Treatment of Alzhimer's Disease,” Dementia & Geriatric Cognitive Disorders 11: 1-10 (2000).
Monyer, H. et al., “Glucose deprivation neuronal injury in cortical culture,” 1989, Brain Research 483:347-354.
Paige, et al., “Estrogen receptor (ER) modulators each induce distinct conformational changes in ER αand ER β,” Proceedings of the National Academy of Sciences of the United States of America 96: 3999-4004 (1999).
Peele, D. B. et al., “Effects of Selection Delays on Radial Maze Performance: Acquisition and Effects of Scopolamine,” Pharmacology, Biochemistry, and Behavior, 29:143-150, (1988)
Pelzer, T. et al., “Estrogen Effects in the Myocardium: Ihibition of NF-κB DNA Binding by Estrogen Receptor-α and -β,” Biochemical & Biophysical Research Communications 286: 1153-7 (2001).
Pike, A. C. W. et al., “Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist,” Embo 18: 4608-4618 (1999).
Quaedackers, M. E. et al., “4-Hydroxytamoxifen Trans-Represses Nuclear Factor-κB Activity in Human Osteoblastic U2-OS Cells through Estrogen Receptor (ER)α, and Not through ERβ,” Endocrinology 142: 1156-1166 (2001).
Sar, M. et al., “Differential Expression of Estrogen Receptor-β and Esrogen Receptor-α in the Rat Ovary,” Endocrinology 140: 963-971 (1999).
Shiau, A. K. et al.,“The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen,” Cell 95: 927-937 (Dec. 23, 1998).
Swenson, R. E. et al., “Synthesis of Substituted Quinolines Using the Dianion Addition ofN-Boc-anilines and α-Tolylsulfonyl- α,β-unsaturated Ketones,”Journal of Organic Chemistry, 2002, 67(26): 9182-9185
Syeda Huma, H. Z. et al., “Cu(I)-catalyzed three

Affiliated with

Also associated with

Rating

Phenyl quinolines and their use as estrogenic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phenyl quinolines and their use as estrogenic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenyl quinolines and their use as estrogenic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4146213